title: Response surface methodology in drug design: A case study on docking analysis of a potent antifungal fluconazole.
abstract: Molecular docking is a valuable in silico technique for discovery/design of bioactive compounds. A current challenge within docking simulations is the incorporation of receptor flexibility. A useful strategy toward solving such problem would be the docking of a typical ligand into the multiple conformations of the target. In this study, a multifactor response surface model was constructed to estimate the AutoDock based binding free energy of fluconazole within multiple conformations of 14α-demethylase (CYP51) (cross docking) as a validated antifungal target. On the basis of developed models, individual and interactive effects of important experimental parameters on cross docking of fluconazole were elucidated. For this purpose, a set of high-resolution holo crystallographic structures from CYP51 of human pathogen Trypanosoma cruzi were retrieved to statistically model the binding mode and affinity of fluconazole. The changes of AutoDock binding free energy for the complexes of CYP51-fluconazole were elucidated with the simultaneous variations of six independent variables including grid size, grid spacing, number of genetic algorithm (GA) runs, maximum number of energy evaluations, torsion degrees for ligand and quaternion degrees for ligand. It was revealed that grid spacing (distance between adjacent grid points) and maximum number of energy evaluations were two significant model terms. It was also revealed that grid size, torsion degrees for ligand and quaternion degrees for ligand had insignificant effects on estimated binding energy while the effect of GA runs was non-significant. The interactive effect of "torsion degrees for ligand" with number of GA runs was found to be the significant factor. Other important interactive effects were the interaction of "number of GA runs" with "grid spacing" and "number of energy evaluations" with "grid size". Furthermore; results of modeling studies within several CYP51 conformations exhibited that "number of GA runs" and "number of energy evaluations" were less sensitive to varied target conformations.
authors.affiliation: Department of Medicinal Chemistry, School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, 5618953141, Iran.
authors.forename: Fatemeh
authors.initials: F
authors.lastname: Bohlooli
authors.affiliation: Department of Medicinal Chemistry, School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, 5618953141, Iran.
authors.forename: Saghi
authors.initials: S
authors.lastname: Sepehri
authors.affiliation: Department of Medicinal Chemistry, School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, 5618953141, Iran. Electronic address: razzaghinima@gmail.com.
authors.forename: Nima
authors.initials: N
authors.lastname: Razzaghi-Asl
mesh_terms: D000935:Antifungal Agents / Q000737:chemistry*; D020134:Catalytic Domain; D003577:Cytochrome P-450 Enzyme System / Q000737:chemistry*; D015195:Drug Design; D015725:Fluconazole / Q000737:chemistry*; D008024:Ligands; D062105:Molecular Docking Simulation; D011487:Protein Conformation; D014349:Trypanosoma cruzi
chemical_list: D000935:Antifungal Agents; C509352:CYP51 protein, Trypanosoma cruzi; D008024:Ligands; D015725:Fluconazole; D003577:Cytochrome P-450 Enzyme System
keywords: Antifungal; Azoles; Box-Behnken; CYP51; Flexible docking